Oncology Department, Consorcio Hospital General Universitario de Valencia; Department of Medicine, Universitat de València; Mixed Unir TRIAL (FIHGUV- CIPF), CIBERONC, Valencia, Spain
Prof. Carlos Camps
Oncology Department, Consorcio Hospital General Universitario de Valencia; Department of Medicine, Universitat de València; Mixed Unir TRIAL (FIHGUV- CIPF), CIBERONC, Valencia, Spain